ISLAMABAD: Preliminary findings of Pakistan’s first comprehensive heart study of 2,000 apparently healthy adults with no symptoms of disease have revealed a heavy burden of cardiac risk factors, with 78 per cent found obese, 33 per cent hypertensive and 22 per cent diabetic, leading cardiologists said on Saturday.
Another 23 per cent of the participants were found to be prediabetic, according to the baseline results presented at the primary prevention session of the 55th CardioCon at the Serena Hotel.
Dr Bashir Hanif, the study’s principal investigator, said obesity, defined by an Asian BMI cut-off of 25, was detected in 81 per cent of women and 74 per cent of men. He said 32 per cent of the participants reported a family history of premature coronary heart disease, while 68 per cent had low levels of “good” HDL cholesterol.
The Pakistan Study of Premature Coronary Atherosclerosis in Young Adults (PAK-SEHAT) is a prospective cohort study being conducted jointly by the Fatima Hanif Foundation and Getz Pharma, which took the initiative through an unrestricted research grant.
Described as the first study of its kind in the country, PAK-SEHAT has been dubbed Pakistan’s “mini Framingham”, after the landmark heart study in the United States.
“The participants, men aged 35 to 60 and women aged 35 to 65, were recruited from all four provinces and Islamabad through eight centres. None has symptomatic cardiovascular disease. Their mean age was 39,” Dr Hanif said.
He said the baseline assessment included blood tests, carotid ultrasound and coronary CT angiography, while the participants would be followed for five years.
Dr Hanif said the findings showed that risk factors did not occur in isolation. Hypertension, dyslipidaemia, obesity and diabetes were found to coexist in the same individuals, and a greater accumulation of these factors corresponded to substantially more silent atherosclerosis.
“Calcium was found in the coronary arteries of 26 per cent of participants,” he said, adding that conventional clinical risk assessment could underestimate the disease actually present.
Dr Khurram Nasir, co-principal investigator and chief of the Division of Cardiovascular Prevention and Wellness at Houston Methodist, said PAK-SEHAT would be a “gold mine” of data for Pakistan.
He said South Asians, particularly Pakistanis, had remained largely “invisible” in global research, leaving little known about the causes, early onset and risk factors of heart disease in them.
Dr Nasir, who is also editor-in-chief of the American Journal of Preventive Cardiology, said the results suggested that being a man aged 35 or above was itself a risk factor for Pakistanis, possibly owing to sedentary lifestyles, genetics and environmental factors. He said further details would emerge once the study was finalised.
He said heart disease appeared to begin 10 to 15 years earlier in Pakistanis than in other populations. However, he said, no one knew why younger people and men suffered early heart attacks and deaths because the question had never been investigated.
PAK-SEHAT, he said, would show why the disease started early and how it could be prevented. He also paid tribute to Dr Hanif and Getz Pharma for making the landmark study possible.
Kashif Amin, Head of Public Health at Getz Pharma, said cardiovascular disease was claiming lives silently in Pakistan, while guidelines and risk-scoring models had relied on Western data. He said prevention must begin with the country’s own data.
He said Getz Pharma’s vision went beyond medicines to shifting from late-stage treatment to primary prevention, with PAK-SEHAT, a multicentric prospective study, at its heart.
Mr Amin said the study was uncovering subclinical atherosclerosis and mapping how hypertension, diabetes, dyslipidaemia and lifestyle factors interact. He described it as a national blueprint for protecting Pakistan’s youth, workforce and families, adding that Getz Pharma would continue connecting clinicians, investigators and the population.
